Skip to main content Skip to main content
Go to homepage

Pfizer seeks approval for vaccine use in younger children

Eric Robinette, MD, MPH, a pediatric infectious disease specialist at Akron Children's, discusses Pfizer's request to have their COVID-19 vaccine approved for children 5-11 years of age.

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.